ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 102 filers reported holding ADURO BIOTECH INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,933,000 | +663.8% | 736,968 | +406.1% | 0.00% | +300.0% |
| Q4 2018 | $384,000 | -79.4% | 145,620 | -42.6% | 0.00% | 0.0% |
| Q3 2018 | $1,866,000 | +110.6% | 253,840 | +100.6% | 0.00% | 0.0% |
| Q2 2018 | $886,000 | +1.7% | 126,533 | +35.2% | 0.00% | 0.0% |
| Q1 2018 | $871,000 | +24.8% | 93,622 | +0.6% | 0.00% | 0.0% |
| Q4 2017 | $698,000 | -13.5% | 93,042 | +22.8% | 0.00% | 0.0% |
| Q3 2017 | $807,000 | -2.3% | 75,746 | +4.5% | 0.00% | 0.0% |
| Q2 2017 | $826,000 | +27.5% | 72,472 | +20.2% | 0.00% | 0.0% |
| Q1 2017 | $648,000 | -5.8% | 60,317 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $688,000 | -0.6% | 60,317 | +8.3% | 0.00% | 0.0% |
| Q3 2016 | $692,000 | +7.3% | 55,692 | -2.3% | 0.00% | 0.0% |
| Q2 2016 | $645,000 | +316.1% | 57,032 | +371.2% | 0.00% | – |
| Q1 2016 | $155,000 | -54.5% | 12,104 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $341,000 | +45.7% | 12,104 | 0.0% | 0.00% | – |
| Q3 2015 | $234,000 | -36.2% | 12,104 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $367,000 | – | 12,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 5,118,560 | $14,025,000 | 1.27% |
| Ikarian Capital, LLC | 3,638,000 | $9,968,000 | 0.75% |
| Rubric Capital Management LP | 871,100 | $2,387,000 | 0.38% |
| Burrage Capital Management LLC | 135,898 | $363,000 | 0.36% |
| Soleus Capital Management, L.P. | 81,200 | $222,000 | 0.26% |
| Artal Group S.A. | 1,000,000 | $2,740,000 | 0.12% |
| BOOTHBAY FUND MANAGEMENT, LLC | 497,857 | $1,364,000 | 0.11% |
| Alambic Investment Management, L.P. | 10,700 | $29,000 | 0.07% |
| LORD, ABBETT & CO. LLC | 1,688,490 | $4,627,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 530,952 | $1,455,000 | 0.02% |